Should we delay adjuvant breast radiotherapy for early stage breast cancers as the COVID-19 situation evolves?

This is a very tough question given the unprecedented nature of this pandemic and the fact that its duration is unknown. Recommendations will likely vary based on the density of cases in a specific geographic location and will undoubtedly change frequently given the rapidly evolving nature of this s...

Agree with what has been posted here and copying the guidance we have issued to our breast doctors at MSKCC, where we are in the midst of the COVID-19 flare.

To improve capacity in the event of personnel shortages, we have divided patients into priority tiers.

• Inflammat...

Many centers on the leading edge of the COVID-19 curve are taking this action for luminal node negative patients based on the references posted already. Expect reduced workforce due to efforts to reserve and protect part of the workforce, workforce in quarantine, and the effect of school closings. D...

Some data suggest it's OK to start endocrine therapy and radiation can be delayed without detriment up to 20 weeks after surgery.

Olivotto et al JCO 2009

I feel comfortable given the current pandemic in delaying RT with endocrine therapy started now for luminal and DCIS.

Also seriously consider whethe...

How will you prioritize new starts when the COVID-19 pandemic is over and you have a backlog of delayed patients and newly diagnosed patients to schedule?